Age-related macular degeneration (AMD)
96 results
1 - 96
Age-related macular degeneration (AMD) 
Macular translocation for neovascular age‐related macular degeneration
B vitamins reduce risk of macular degeneration in women- Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age‐related macular degeneration
- Omega 3 fatty acids for preventing or slowing the progression of age‐related macular degeneration
- Long-term aspirin use minimally increases risk of age-related macular degeneration
- Antioxidants do not prevent macular degeneration
- Central serous retinopathy
- Submacular surgery for choroidal neovascularisation secondary to age‐related macular degeneration
- Surgery for cataracts in people with age‐related macular degeneration
- Antioxidant vitamin and mineral supplements for slowing the progression of age‐related macular degeneration
- Ginkgo biloba extract for age‐related macular degeneration
- Laser photocoagulation for neovascular age‐related macular degeneration
- Implantable miniature telescope (IMT) for vision loss due to end-stage age-related macular degeneration: Cochrane systematic review
- Statins for age‐related macular degeneration
- Antiangiogenic therapy with interferon alfa for neovascular age‐related macular degeneration
- Aflibercept for neovascular age‐related macular degeneration
- Carotenoids and omega-3 fatty acids do not reduce risk of advanced AMD
- Complement inhibitors for age‐related macular degeneration
- Laser treatment of drusen to prevent progression to advanced age‐related macular degeneration
- Antioxidant vitamin and mineral supplements for preventing age‐related macular degeneration
- Photobiomodulation for non‐exudative age‐related macular degeneration
- Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age‐related macular degeneration
- Ocular adverse effects of systemic medication
- Vitreous haemorrhage (VH)
- Statins for age-related macular degeneration
- Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration
- Radiotherapy for neovascular age‐related macular degeneration
- Photodynamic therapy for neovascular age‐related macular degeneration
- Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration
- Artificial intelligence for diagnosing exudative age‐related macular degeneration
- Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration: Cochrane systematic review
- Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration
- Photodynamic therapy for neovascular age-related macular degeneration
- Carotenoids and omega-3 fatty acids do not effect rate of cognitive function decline
- Anti‐vascular endothelial growth factor biosimilars for neovascular age‐related macular degeneration
- Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration
- Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
- Blue‐light filtering intraocular lenses (IOLs) for protecting macular health
- Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration
- Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults
- Reading aids for adults with low vision
- Low vision rehabilitation for better quality of life in visually impaired adults